ALFA Finder
16:17 IST
BSE
Other Announcement
Norris Medicines Other Announcement
Norris Medicines Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required by SEBI regulations.
Norris Medicines Ltd
- Share price
- ₹14.25
- Market cap
- ₹14.25 Cr
- Revenue (annual)
- ₹8.13 Cr
- Net profit (annual)
- ₹-0.28 Cr
- P/E (TTM)
- -38.8×Sector 43.8×
- Promoter holding
- 34.01%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 3Board Meeting Date 3Other Announcement 2Annual General Meeting 2Management Change 1Annual Report 1
Time
2 announcements with these filters
11:19 IST
BSE
Other Announcement
Norris Medicines Other Announcement
Norris Medicines Ltd filed its quarterly shareholding pattern as of June 30, 2026. The document lists promoter and public holdings per Regulation 31.